Journal of Capital Medical University ›› 2021, Vol. 42 ›› Issue (5): 883-887.doi: 10.3969/j.issn.1006-7795.2021.05.031

• Nobel Prize • Previous Articles     Next Articles

Asymmetric organocatalysis: making pharmaceutical development simple—Introduction of the Nobel Prize in Chemistry 2021

Li Yuanyuan, Feng Qiqi, Zhang Xiaoyi, Wang Yuji*, Zhao Ming*   

  1. Engineering Research Center of Endogenous Prophylactic of Ministry of Education, Major Laboratory of Peptide and Small Molecular Drugs, Beijing Laboratory of Biomedical Materials and Key Laboratory of Biomedical Materials of Natural Macromolecules, Department of Medicinal Chemistry, School of Pharmaceutical Sciences, Capital Medical University, Beijing 100069, China
  • Received:2021-10-11 Published:2021-10-29

PDF

107

Abstract: On October 6, 2021, the Royal Swedish Academy of Sciences announced that the Nobel Prize in Chemistry 2021 was awarded to German chemist Benjamin List and the American chemist David W.C. MacMillan, in recognition of their outstanding contributions in the development of asymmetric organocatalysis.

Key words: the Nobel Prize in Chemistry 2021, asymmetric organocatalysis, chiral molecules

CLC Number: